J. Furuse

机构：Kanagawa Prefectural Hospital Organization, Kanagawa Cancer Center

发表论文 4 篇 · 总被引 357 次 · h-index 3

代表论文

• Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (2024 · Annals of Oncology · 被引 343)
• 83P Impact of viral aetiology in the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC) (2022 · Annals of Oncology · 被引 8)
• 1494P Pooled efficacy and safety outcomes with tremelimumab plus durvalumab in participants (pts) with unresectable hepatocellular carcinoma (uHCC) from the combined China extension and global cohorts in the phase III HIMALAYA study (2025 · Annals of Oncology · 被引 5)
• 67O Outcomes in the Asian subgroup of the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC) (2022 · Annals of Oncology · 被引 2)